197 related articles for article (PubMed ID: 18226630)
1. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.
Ueda SM; Kapp DS; Cheung MK; Shin JY; Osann K; Husain A; Teng NN; Berek JS; Chan JK
Am J Obstet Gynecol; 2008 Feb; 198(2):218.e1-6. PubMed ID: 18226630
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
Chan JK; Kapp DS; Cheung MK; Shin JY; Stieglitz D; Husain A; Teng NN; Berek JS; Osann K; Guo H
Am J Obstet Gynecol; 2008 Feb; 198(2):216.e1-5. PubMed ID: 18226629
[TBL] [Abstract][Full Text] [Related]
3. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
4. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?
Chan JK; Manuel MR; Cheung MK; Osann K; Husain A; Teng NN; Rao A; Carlson RW; Whittemore AS
Gynecol Oncol; 2006 Sep; 102(3):508-12. PubMed ID: 16483640
[TBL] [Abstract][Full Text] [Related]
6. Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
Farley JH; Nycum LR; Birrer MJ; Park RC; Taylor RR
Gynecol Oncol; 2000 Oct; 79(1):86-9. PubMed ID: 11006037
[TBL] [Abstract][Full Text] [Related]
7. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for uterine cancer in reproductive-aged women.
Lee NK; Cheung MK; Shin JY; Husain A; Teng NN; Berek JS; Kapp DS; Osann K; Chan JK
Obstet Gynecol; 2007 Mar; 109(3):655-62. PubMed ID: 17329517
[TBL] [Abstract][Full Text] [Related]
9. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiation therapy in stage III node-positive uterine cancer.
Schmid S; Hsu IC; Hu JM; Sherman AE; Osann K; Kapp DS; Chan JK
Gynecol Oncol; 2009 Nov; 115(2):239-43. PubMed ID: 19679341
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
13. Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment.
Díaz-Montes TP; Alberg A; Zahurak ML; Trimble EL; Bristow RE
Gynecol Oncol; 2005 Mar; 96(3):753-9. PubMed ID: 15721422
[TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
Rauh-Hain JA; Davis M; Clemmer J; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Nov; 131(2):404-9. PubMed ID: 24004647
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma of the cervix: natural history and outcomes.
Bansal S; Lewin SN; Burke WM; Deutsch I; Sun X; Herzog TJ; Wright JD
Gynecol Oncol; 2010 Aug; 118(2):134-8. PubMed ID: 20541244
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
18. Primary scrotal cancer: disease characteristics and increasing incidence.
Wright JL; Morgan TM; Lin DW
Urology; 2008 Nov; 72(5):1139-43. PubMed ID: 18799208
[TBL] [Abstract][Full Text] [Related]
19. A comparison of younger vs older women with vulvar cancer in the United States.
Kumar S; Shah JP; Bryant CS; Imudia AN; Morris RT; Malone JM
Am J Obstet Gynecol; 2009 May; 200(5):e52-5. PubMed ID: 19110228
[TBL] [Abstract][Full Text] [Related]
20. Uterine cancer--the KK Hospital experience.
Tan YY; Ho TH
Singapore Med J; 1996 Dec; 37(6):600-3. PubMed ID: 9104059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
